ArticleGland surgery2026
The comparison outcome of implant-based breast reconstruction with acellular dermal matrix, non-acellular dermal matrix and TiLOOP
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Implant-based breast reconstruction after mastectomy in breast cancer patients has been increasingly performed over the past decade, improving cosmetic outcomes. The use of supportive matrices has increased in recent years. This study aimed to compare the outcomes of implant-based breast reconstruction between acellular dermal matrix (ADM), non-ADM, and TiLOOP Methods: A retrospective descriptive study, a case series from consecutive patients with breast cancer who underwent mastectomy with implant-based breast reconstruction using ADM, non-ADM, or TiLOOP Results: A total of 36 breast cancer patients (ages between 22 and 64 years old) who underwent unilateral or bilateral mastectomy with implant-based breast reconstruction were organized into three categories of ADM, non-ADM, and TiLOOP Conclusions: No significant difference in complication between ADM, non-ADM and TiLOOP
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.